Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort

Background: Bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) is a recommended once-daily single-tablet regimen for the treatment of people living with HIV (PLWH). We aimed to assess efficacy, safety, and tolerability of BIC/FTC/TAF among PLWH, with a specific focus on people ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzaro, Alessandro, Bianchini, Diana, Gentilini Cacciola, Elio, Mezzaroma, Ivano, Falciano, Mario, Andreoni, Carolina, Fimiani, Caterina, Santinelli, Letizia, Maddaloni, Luca, Bugani, Ginevra, Ceccarelli, Giancarlo, Mastroianni, Claudio Maria, d’Ettorre, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302527/
https://www.ncbi.nlm.nih.gov/pubmed/37376522
http://dx.doi.org/10.3390/v15061222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302527/
https://www.ncbi.nlm.nih.gov/pubmed/37376522
http://dx.doi.org/10.3390/v15061222

Ejemplares similares